Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
Ugeskrift for Laeger
|
October 28, 2021
[Hereditary anaemias]
Andreas Glenthøj
Haematologica
|
April 18, 2024
Beyond adenosine triphosphate: unveiling the pleiotropic effects of pyruvate kinase activation in sickle cell anemia
Andreas Glenthøj
Hemoglobin
|
July 26, 2021
Hb A<sub>2</sub>-Calderdale [δ2(NA2)His→Asn; <i>HBD</i>: c.7C>A] and Misdiagnosis of Type 2 Diabetes Mellitus Due to Interference with Hb A<sub>1c</sub> When Using Cation Exchange High Performance Liquid Chromatography: A Case Report
Ida Stangerup, Jesper Petersen, Andreas Glenthøj
European Journal of Heart Failure
|
January 24, 2023
Letter regarding the article 'Little at a time: trying to understand the battery of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure'
Camilla Fuchs Andersen, Andreas Glenthøj, Jesper Jensen
European Journal of Clinical Investigation
|
May 31, 2013
ProHNPs are the principal α-defensins of human plasma
Andreas Glenthøj, Anders J Glenthøj, Niels Borregaard
Hemoglobin
|
April 2, 2024
Thrombosis Tendency After Splenectomy in a Danish Family With Hemoglobin Volga, and a Literature Review
Johanne Kodal Breinholt, Andreas Glenthøj, Mustafa Vakur Bor
Plos One
|
May 7, 2015
Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo
Andreas Glenthøj, Katrin Nickles, Jack Cowland, et al.
Ugeskrift for Laeger
|
October 29, 2020
[Sickle cell disease and pregnancy]
Thomas Christensen, Amina Nardo-Marino, Andreas Glenthøj, et al.
Hemoglobin
|
July 4, 2024
A Novel β-Globin Variant, Hb Odder [<i>HBB</i>: C.316C > G; CD105 (Leu > Val)]
Esther Agnethe Ejskjær Gravholt, Jesper Petersen, Morten Mørk, et al.
Lancet (London, England)
|
March 15, 2026
Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential
Thomas Doeven, Andreas Glenthøj, Rachael F Grace, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
Ugeskrift for Laeger
|
October 28, 2021
[Hereditary anaemias]
Andreas Glenthøj
Haematologica
|
April 18, 2024
Beyond adenosine triphosphate: unveiling the pleiotropic effects of pyruvate kinase activation in sickle cell anemia
Andreas Glenthøj
Hemoglobin
|
July 26, 2021
Hb A<sub>2</sub>-Calderdale [δ2(NA2)His→Asn; <i>HBD</i>: c.7C>A] and Misdiagnosis of Type 2 Diabetes Mellitus Due to Interference with Hb A<sub>1c</sub> When Using Cation Exchange High Performance Liquid Chromatography: A Case Report
Ida Stangerup, Jesper Petersen, Andreas Glenthøj
European Journal of Heart Failure
|
January 24, 2023
Letter regarding the article 'Little at a time: trying to understand the battery of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure'
Camilla Fuchs Andersen, Andreas Glenthøj, Jesper Jensen
European Journal of Clinical Investigation
|
May 31, 2013
ProHNPs are the principal α-defensins of human plasma
Andreas Glenthøj, Anders J Glenthøj, Niels Borregaard
Hemoglobin
|
April 2, 2024
Thrombosis Tendency After Splenectomy in a Danish Family With Hemoglobin Volga, and a Literature Review
Johanne Kodal Breinholt, Andreas Glenthøj, Mustafa Vakur Bor
Plos One
|
May 7, 2015
Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo
Andreas Glenthøj, Katrin Nickles, Jack Cowland, et al.
Ugeskrift for Laeger
|
October 29, 2020
[Sickle cell disease and pregnancy]
Thomas Christensen, Amina Nardo-Marino, Andreas Glenthøj, et al.
Hemoglobin
|
July 4, 2024
A Novel β-Globin Variant, Hb Odder [<i>HBB</i>: C.316C > G; CD105 (Leu > Val)]
Esther Agnethe Ejskjær Gravholt, Jesper Petersen, Morten Mørk, et al.
Lancet (London, England)
|
March 15, 2026
Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential
Thomas Doeven, Andreas Glenthøj, Rachael F Grace, et al.
Page
of 12